A cross-sectional survey to assess the feasibility and acceptability of seasonal malaria chemoprevention in Karamoja region, Uganda

Authors: Anthony Nuwa, Kevin Nicholas Baker, Craig Bonnington, Musa Odongo, Tonny Kyagulanyi, Sol Richardson, Jane Nabakooza, Richard Kajuubi, David Salandini Odong, Maureen Naakirunda, Godfrey Magumba, Geofrey Beinomugisha, Madeleine Marasciulo-Rice, Stella Bakeera, Chrisestome Muhereza, Hilda Abio, Christian Rassi, Damian Rutazaana, Denis Rubahika, James Tibenderana, Jimmy Opigo

SMC was feasible and acceptable among all included stakeholders at the national, district and community level, including the nomadic pastoralist communities.

In 2021, the Ministry of Health, Uganda, collaborated with Malaria Consortium to conduct a five-month phase 1 implementation study to assess the acceptability and feasibility of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) and amodiaquine (SPAQ) in two districts of Karamoja region, where malaria transmission is highly seasonal.

This poster was presented at the Multilateral Initiative on Malaria (MIM) Society's 8th Pan-African Malaria Conference.